“

We've been mostly focused on monoclonal antibodies and to some degree, remdesivir and some of the other immunomodulators, but we really need to be thinking about other antivirals, here I am speaking as a member of Infectious Diseases Society of America -- the Infectious Diseases Society of America. Infectious Diseases Society of America still does not recommend the use of monoclonal antibodies, despite emergency use authorization being granted by the FDA.